7 Stocks Under $10 Spiking Toward Big Gains

As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Stocks that are in favor and making large moves is a segment of the market that I tweet about on a regular basis.These are also the exact type of stocks that I love to trade and alert to my subscribers in real-time.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Bellicum Pharmaceuticals

  • Friday's Range: $8.61-$9.26
  • 52-Week Range: $7.24-$29.33
  • Friday's Volume: 383,000
  • Three-Month Average Volume: 368,270

Bellicum Pharmaceuticals  (BLCM) , a clinical stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers, solid tumors and orphan inherited blood disorders in the U.S. and internationally. This stock closed up 3.2% to $9.16 in Friday's trading session.

From a technical perspective, Bellicum Pharmaceuticals ripped higher on Friday right off a downtrend line that dates back to March with above-average volume. This stock recently sold off from its high of $11.96 a share to its recent low of $8.61 a share. During that selloff, shares of Bellicum Pharmaceuticals has been making mostly lower highs and lower lows, which is bearish technical price action. Market players should now look for a continuation move to the upside in the short-term if this stock manages to clear Friday's intraday high of $9.26 a share with strong upside volume flows.

Traders should now look for long-biased trades in Bellicum Pharmaceuticals long as it's trending above Friday's intraday low of $8.61 a share and then once it sustains a move or close above Friday's intraday high of $9.26 a share with volume that hits near or above 368,270 shares. If that move gets started soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $9.84 to $10.32, or even its 20-day moving average of $10.52 to $11 a share.

TransEnterix

  • Friday's Range: $1.80-$1.98
  • 52-Week Range: $1.28-$6.10
  • Friday's Volume: 2.76 million
  • Three-Month Average Volume: 3.02 million

TransEnterix  (TRXC) , a medical device company, focuses on the development and commercialization of surgical robotic systems. This stock traded up 11.4% to $1.95 in Friday's trading session.

From a technical perspective, TransEnterix exploded sharply higher on Friday and broke out above some near-term overhead resistance at $1.80 a share with decent upside volume flows. This stock has been uptrending over the last few trading sessions, with shares moving higher off its low of $1.47 a share to its intraday high on Friday of $1.98 a share. During that uptrend, this stock has been consistently making higher lows and higher highs, which is bullish technical price action. Market players should now look for a continuation move to the upside in the short-term if shares of TransEnterix manages to clear Friday's intraday high of $1.98 with strong upside volume flows.

Traders should now look for long-biased trades in TransEnterix s as long as it's trending above Friday's intraday low of $1.80 a share and then once it sustains a move or close above Friday's intraday high of $1.98 a share with volume that hits near or above 3.02 million shares. If that move gets underway soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $2.15 to its gap-down-day high of around $2.56 a share. Any high-volume move above $2.56 will then give this stock a chance to tag $3 a share.

MobileIron

  • Friday's Range: $2.95-$3.20
  • 52-Week Range: $2.81-$7.10
  • Friday's Volume: 390,000
  • Three-Month Average Volume: 284,281

MobileIron  (MOBL)  provides a purpose-built mobile IT platform that enables enterprises to secure and manage mobile applications, content and devices while providing their employees with device choice, privacy and a native user experience. This stock traded up 1.9% to $3.18 in Friday's trading session.

From a technical perspective, MobileIron trended higher on Friday right above its 52-week low of $2.81 a share with strong upside volume flows. This stock has been downtrending badly over the last month, with shares collapsing off its high of $4.78 a share to Friday's intraday low of $2.95 a share. During that downtrend, shares of MobileIron have been making mostly lower highs and lower lows, which is bearish technical price action. That said, this stock has now started to bounce off oversold levels, since its current relative strength index ready is 18.37. Oversold can always get more oversold, but it's also an area where a stock can make a powerful bounce higher from. Market players should now look for a continuation move to the upside in the short-term if shares of MobileIron manages to clear Friday's intraday high of $3.20 a share with strong volume.

Traders should now look for long-biased trades in MobileIron as long as it's trending above Friday's intraday low of $2.95 a share and then once it sustains a move or close above Friday's intraday high of $3.20 a share with volume that hits near or above 284,281 shares. If that move gets started soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $3.30 to $3.40, or even $3.80 a share.

GenVec

GenVec  (GNVC) , a clinical-stage biopharmaceutical company, focuses on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform in the U.S. This stock traded up 6.4% to 72 cents per share in Friday's trading session.

  • Friday's Range: $0.69-$0.79
  • 52-Week Range: $0.35-$3.69
  • Friday's Volume: 263,000
  • Three-Month Average Volume: 162,832

From a technical perspective, GenVec spiked sharply higher on Friday right into its 50-day moving average of 74 cents per share with above-average volume. This spike also briefly pushed this stock into its 20-day moving average of 80 cents per share, before it pulled back and closed at 74 cents per share. This move is now starting to push shares of GenVec within range of triggering a near-term breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at 80 to 83 cents per share and then above more resistance at 90 cents per share with high volume.

Traders should now look for long-biased trades in GenVec as long as it's trending above Friday's intraday low of 69 cents per share and then once it sustains a move or close above those breakout levels with volume that hits near or above 162,832 shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $1 to $1.08, or even $1.40 a share.

Argos Therapeutics

  • Friday's Range: $5.11-$5.94
  • 52-Week Range: $1.61-$13.97
  • Friday's Volume: 895,000
  • Three-Month Average Volume: 388,352

Argos Therapeutics  (ARGS)  focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. This stock traded up 13.5% to $5.85 in Friday's trading session.

From a technical perspective, Argos Therapeutics ripped sharply higher on Friday right above its 200-day moving average of $4.99 a share with strong upside volume flows. This stock has been downtrending badly over the last month, with shares falling off its high of $13.97 a share to its recent low of $4.75 a share. During that downtrend, shares of Argos Therapeutics have been making mostly lower highs and lower lows, which is bearish technical price action. That said, this stock has now started to rebound off that $4.75 low with strong upside volume flows. That rebound is now quickly pushing this stock within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out Friday's intraday high of $5.94 a share to $6 a share with high volume.

Traders should now look for long-biased trades in Argos Therapeutics as long as it's trending above its 200-day moving average of $5.94 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 388,352 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $6.52 to $7 a share, or even its 20-day moving average of $7.75 a share.

Accuride

  • Friday's Range: $1.57-$1.70
  • 52-Week Range: $0.74-$4.67
  • Friday's Volume: 365,000
  • Three-Month Average Volume: 238,021

Accuride  (ACW)  designs, manufacturesand distributes commercial vehicle components in North America. This stock traded up 5% to $1.68 in Friday's trading session.

From a technical perspective, Accuride ripped sharply higher on Friday right off its 50-day moving average of $1.57 a share with strong upside volume flows. This high-volume rip to the upside is now quickly pushing shares of Accuride within range of triggering a major breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $1.70 to $1.72 a share and then above more key resistance at $1.80 a share with high volume.

Traders should now look for long-biased trades in Accuride as long as it's trending above its 50-day moving average of $1.57 a share or above more near-term support levels at $1.50 to $1.40 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 238,021 shares. If that breakout hits soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $2.20 to its 200-day moving average of $2.22, or even $2.50 a share.

Walter Investment Management

  • Friday's Range: $4.35-$4.66
  • 52-Week Range: $4.31-$23.70
  • Friday's Volume: 397,000
  • Three-Month Average Volume: 305,144

Walter Investment Management  (WAC) , a diversified mortgage banking firm, focuses primarily on the servicing and origination of residential loans in the U.S. This stock traded up 5.9% to $4.65 in Friday's trading session.

From a technical perspective, Walter Investment Management spiked sharply higher on Friday right above its new 52-week low of $4.31 a share with strong upside volume flows. This stock recently gapped-down sharply lower from over $7 a share to around $5 a share with monster downside volume flows. Following that move, shares of Walter Investment Management went on to a hit a new 52-week low of $4.31 a share. That said, this stock has now started to rebound off that $4.31 low and off extremely oversold levels, since its current relative strength index reading is 22.9. Oversold can always get more oversold, but this is also an area where a stock can experience a powerful bounce higher from. Market players should now look for a continuation move to the upside in the short-term if this stock manages to take out Friday's intraday high of $4.66 a share with strong upside volume flows.

Traders should now look for long-biased trades in Walter Investment Management as long as it's trending above its new 52-week low of $4.31 a share and then once it sustains a move or close above Friday's intraday high of $4.66 a share with volume that registers near or above 305,144 shares. If that move gets underway soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $5.25 to around $6 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.

More from Opinion

Netflix Tanks on Disappointing Subscriber Numbers: 10 Key Takeaways

Netflix Tanks on Disappointing Subscriber Numbers: 10 Key Takeaways

Tesla's Elon Musk Must Realize He Can't Do It All: Dumbest Thing on Wall Street

Tesla's Elon Musk Must Realize He Can't Do It All: Dumbest Thing on Wall Street

5 Things to Watch for When Netflix Reports Earnings on Monday

5 Things to Watch for When Netflix Reports Earnings on Monday

Flashback Friday: Bank Stocks Stay Hot and Tesla Stays Relevant

Flashback Friday: Bank Stocks Stay Hot and Tesla Stays Relevant

Throwback Thursday: Tesla's Risky, Broadcom Slips, Papa John's Jumps

Throwback Thursday: Tesla's Risky, Broadcom Slips, Papa John's Jumps